Evidence map›Paper›PMID 30697960›Full record

ArticleThe journal of pathology. Clinical research2019

Comprehensive three-dimensional morphology of neoangiogenesis in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.

Lavinia Neubert, Paul Borchert, Hoen-Oh Shin, Friedemann Linz, Willi L Wagner, Gregor Warnecke, Florian Laenger, Axel Haverich, Helge Stark, Marius M Hoeper and 3 more

Open access · goldAbstract read
In one paragraph

Article in The journal of pathology. Clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Pulmonary capillary haemangiomatosis: a distinct entity?European respiratory review : an official journal of the European Respiratory Society · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Lavinia NeubertInstitute of Pathology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-4130-4185
Paul BorchertInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Hoen-Oh ShinMember of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.
Friedemann LinzInstitute of Functional and Clinical Anatomy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Willi L WagnerDepartment of Diagnostic and Interventional Radiology, University of Heidelberg, Heidelberg, Germany.
Gregor WarneckeMember of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.
Florian LaengerInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Axel HaverichMember of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.
Helge StarkInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Marius M HoeperMember of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.
Mark KuehnelInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Maximilian AckermannInstitute of Functional and Clinical Anatomy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Danny JonigkInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DEJohannes Gutenberg University Mainz · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare lung disease characterized by fibrotic narrowing of pulmonary veins leading to pulmonary hypertension (PH) and finally to death by right heart failure. PVOD is often accompanied by pulmonary capillary hemangiomatosis (PCH), a marked abnormal proliferation of pulmonary capillaries. Both morphological patterns often occur together and are thought to be distinct manifestations of the same disease process and accordingly are classified together in group 1' of the Nice classification of PH. The underlying mechanisms of these aberrant remodeling processes remain poorly understood. In this study, we investigated the three-dimensional structure of these vascular lesions in the lung explant of a patient diagnosed with PVOD by μ-computed tomography, microvascular corrosion casting, electron microscopy, immunohistochemistry, correlative light microscopy and gene expression analysis. We were able to describe multifocal intussusceptive neoangiogenesis and vascular sprouting as the three-dimensional correlate of progressive PCH, a process dividing pre-existing vessels by intravascular pillar formation previously only known from embryogenesis and tumor neoangiogenesis. Our findings suggest that venous occlusions in PVOD increase shear and stretching forces in the pulmonary capillary bloodstream and thereby induce intussusceptive neoangiogenesis. These findings can serve as a basis for novel approaches to the analysis of PVOD.

Indexed as

Hemangioma, CapillaryHumansHypertension, PulmonaryLung NeoplasmsNeovascularization, PathologicPulmonary VeinsPulmonary Veno-Occlusive Diseaseintussusceptive neoangiogenesispulmonary capillary hemangiomatosispulmonary hypertensionpulmonary vascular remodelingpulmonary veno-occlusive disease

Identifiers

PMID30697960
PMCPMC6463863
OpenAlexW2913431580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.